Karen Sagher

Combined Cytotoxic and Immune Therapy for Primary Adult High-Grade Glioma

T. Lawrence, L. Junck, D. Orringer, 2022, medRxiv.

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.

Patrick J. Dunn, T. Lawrence, L. Junck, 2023, The Lancet. Oncology.